维普中文期刊产品整合服务
232篇 您的检索式:作者名="Tripepi G"
    题名 作者 年代 出处 被引量
1Low triiodothyronine:a new facet of inflammation in end-stage renal disease显示文摘 Tripepi G Cutrupi S 2005J Am Soc Nephrol2005,16,9:1
2Blood pressure variability in chronic kidney disease patients 显示文摘MALLAMACI F1 TRIPEPI G 2013Blood Purif2013,36,1:1
3Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease显示文摘Zoccali C Mallamaci F Tripepi G Benedetto FA Cutrupi S Parlongo S Malatino LS Bonanno G Seminara G Rapisarda F Fatuzzo P Buemi M Nicocia G Tanaka S Ouchi N Kihara S Funahashi T Matsuzawa Y 2002J Am Soc Nephrol2002,13,1:1
4Novel cardiovascular risk factors in end-stage renal disease显示文摘Zoccali C Mallamaci F Tripepi G 2004J Am Soc Nephrol2004,15,1:1
5血清碱性磷酸酶对未治疗的高血压患者的内皮依赖性血管舒张的不良影响显示文摘组织非特异性碱性磷酸酶是一般人群和肾或心血管病患者总死亡率及心血管死亡率的强有力预测因子。该研究纳入未经治疗的高血压患者500例,按照血清碱性磷酸酶三分位分组,分析血清碱性磷酸酶水平和血管内皮功能(通过应变仪体积描记法评估)可能存在的关联。结果:血管对乙酰胆碱的最大反应与碱性磷酸酶水平呈负相关(r=一0.55,P〈0.01),该相关性独立于人口和传统危险因素,如体质量指数,估算的肾小球滤过率,血清磷和钙,C反应蛋白和蛋白尿。刘莉 叶鹏 Perticone F Perticone M Maio R Sciacqua A Andreucci M Tripepi G Corrao S Mallamaci F Sesti G Zoccali C 2015中华高血压杂志2015,23,8:1
6Inflammation markers,adhesion molecules,and all-cause and cardiovascular mortality in patients with ESRD:searching for the best risk marker by multivariate modeling显示文摘 Mallamaci F Zoccali C 2005J Am Soc Nephrol2005,16,1:1
7Vitamin D levels and patient outcome in chronic kidney disease 显示文摘Ravani P Malberti F Tripepi G 2009Kidney Int2009,75,1:1
8Novel cardiovascular risk factors in end-stage renal disease显示文摘Zoccali C Mallamaci F Tripepi G 2004J Am Soc Nephrol2004,15,1:1
9Novel cardiovascularrisk factors in end-stage renal disease显示文摘Zoccali C Mallamaci F Tripepi G 2004J Am SocNephrol2004,15,:1
10Predictors of cardio- vascular death in ESRD显示文摘ZOCCALI C TRIPEPI G MALLAMACI F 2005Semin Nephrol2005,25,6:1
11Cardiac consequences of hypertension in hemodialysis patients 显示文摘Zoccali C Benedetto FA Tripepi G 2004Semin Dial2004,17,:1
12Leptin in end stage renal disease:A link between fat mass,bone and the cardiovascular system显示文摘Mallamaci F Tripepi G Zoccali C 2005J Nephrol2005,18,:1
13Dissecting inflamma-tion in ESRD:do cytokines and C-reactive protein havea complementary prognostic value for mortality in dial-ysis patients?显示文摘Zoccali C Tripepi G Mallamaci F 2006J Am Soc Nephrol2006,17,123:1
14Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD : Searching for the best risk marker by multivariate mod- eling显示文摘Tripepi G Mallamaci F Zoccali C 2005J Am Soe Nephrol2005,16,31:1
15Adiponectin, Metabolic risk factors, and cardiovascular events among patients with endstage renal disease显示文摘Zoccali C Mallamaci F Tripepi G 2002J Am Soc Nephrol2002,13,1:1
16Cardiac consequences of hypertension in hemodialysis patients显示文摘Zoccali C Benedetto FA Tripepi G 2004Semin Dial2004,17,4:1
17Leptin in end stage renal disease: a link between fat mass, bone and the cardiovascular system 显示文摘Mallamaci F Tripepi G Zoccali C 2005J Neph- rol2005,18,:1
18Leptin and biochemicalmarkers of bone turnover in dialysis patients显示文摘Zoccali C Panuccio V Tripepi G 0,,02:1
19Dissecting lnfammation in ESRD: Do cytokines and C-Reactive protein have a complementary prognostic vaule for mortality in patient显示文摘Zoccali C Tripepi G Mallamaci F 2006J Am Soc Nephorl2006,17,123:1
20Adiponectin,metabolicrisk factors, and cardiovascular events among patients with end-stage renal disease 显示文摘Zoccali C Mallamaci F Tripepi G 2002J Am Soc Nephrol2002,13,1:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费